Emerging Europe Monitor

Comprehensive country-by-country macroeconomic analysis, risk appraisals, latest market data and forecasts for Emerging Europe

See Prices or Subscribe

Key stories from this month's issue...

Industry Trend Analysis - Euro Appreciation Will Boost Market Growth - JAN 2018

Central Europe & Baltic States November 2017 / Estonia / Industry

The Estonian medical device market will record high single-digit growth in local currency terms as the economy outperforms, while it will register higher growth in US dollar terms on the back of a stronger outlook for the euro. The market will benefit from positive drivers such as the ageing population and government investment in primary healthcare services, while the low proportion of GDP spent on health and the small domestic industry will restrict market growth.


Political Risk Analysis - Ruling Party Presidential Win Positive For Policy Continuity - JAN 2018

Russia & CIS November 2017 / Kyrgyzstan / Political Risk

Sooronbay Jeenbekov from Kyrgyzstan's ruling Social Democratic Party looks set to become the next president of Kyrgyzstan and his election is likely to be positive for policy continuity, enabling the government to continue with its existing development initiatives. However, we cannot rule out the possibility of runner up Omurbek Babanov's supporters launching protests against the government, with Babanov showing no signs of having accepted the results. In view of the possible risks to social stability and continued political uncertainty, we maintain our short-term political risk score of 56.3.


Industry Trend Analysis - Risks Rising In Romanian Pharmaceutical Market - JAN 2018

South East Europe November 2017 / Romania / Industry

Political instability, healthcare financing issues and aggressive pricing policies will pose significant challenges to drugmakers in Romania. While medicine sales growth is forecast to remain robust over the coming years, these growing challenges indicate that the market is becoming less attractive to investment. We note that the growth of the private healthcare sector may attenuate some of these headwinds.